

This product is intended for use by medical professionals only. If you are an active licensed physician and wish to place an order please contact our team to create an account before placing an order.
YOUR ORDER WILL NOT BE SHIPPED WITHOUT PRIOR ACCOUNT ACTIVATION AND VERIFICATION.
Allogeneic PRP vs autologous PRP
While autologous PRP has been widely used and has demonstrated safety and effectiveness in the treatment of various wounds and soft tissue injuries, it has some limitations. One of the primary limitations of autologous PRP is that it requires the harvesting of a patient’s own blood, which is not feasible or safe in all cases. For example, elderly patients, neonates, or individuals unable to donate large quantities of blood may not be able to undergo the procedure. Additionally, the quality and quantity of platelets obtained from a patient’s own blood can vary depending on factors such as age, health status, and medication use.
Allogeneic PRP, on the other hand, is obtained from a donor and can be used as an off-the-shelf therapy for wound repair and musculoskeletal injuries. This eliminates the need for blood harvesting from the patient, making it a more convenient and feasible option for a broader range of patients. Additionally, allogeneic PRP can provide a more standardized and consistent product, as the platelet concentration and quality can be controlled during the manufacturing process.
Furthermore, allogeneic PRP can provide greater amounts of platelet-derived bioactive factors, including growth factors and cytokines, which can promote tissue repair and regeneration. This is because allogeneic PRP is often prepared from a pool of
donors, allowing for a higher concentration of platelets and bioactive factors to be obtained than can be possible with autologous PRP. In addition, allogeneic PRP contains a more diverse array of bioactive factors, as different donors have variations in their platelet composition.
Allogeneic PRP is less costly and time-consuming than autologous PRP, as it eliminates the need for blood harvesting and processing from the patient. This makes the treatment more accessible to patients and healthcare providers.
